NEW YORK (GenomeWeb News) – DNAPrint Genomics today said it and a Spanish biotech will try to identify genes linked to how individuals with ovarian cancer respond to certain chemotherapeutic agents.
 
Terms of the deal call for DNAPrint to test DNA samples collected by NeoCodex of Seville to study “the effectiveness of certain treatments for ovarian cancer” involving Taxotere, Taxol, Carboplatin, and Cisplatin.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.